Interestingly, bioactive constituents which simultaneously inhibit α-glucosidase and PTP1B enzymes display synergistic effect to antagonize hyperglycaemia and hence significantly improve insulin sensitization. The gene discussed is INS; the disease is Hyperglycemia.